Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Papillomavirus Infections 22Uterine Cervical Neoplasms 18Uterine Cervical Dysplasia 6Condylomata Acuminata 6Anus Neoplasms 5Vulvar Neoplasms 4Vaginal Neoplasms 3HIV Infections 2Whooping Cough 1Virus Diseases 1Tetanus 1Persistent Infection 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Neoplasm Metastasis 1Meningitis 1Lung Neoplasms 1Keratosis, Actinic 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Genital Human Papilloma Virus Infection 1Endometrial Neoplasms 1Diphtheria 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Acquired Immunodeficiency Syndrome 1

Interventions

Cisplatin 253Radiotherapy 176Cetuximab 145pembrolizumab 120Docetaxel 97Fluorouracil 92Carboplatin 80Paclitaxel 77Radiotherapy, Intensity-Modulated 69Nivolumab 37Radiation 30Drug Therapy 30Erlotinib Hydrochloride 26Gemcitabine 25Cyclophosphamide 22Gefitinib 21Surveys and Questionnaires 20Standard of Care 20Surgical Procedures, Operative 19Pemetrexed 19durvalumab 18Magnetic Resonance Spectroscopy 17Capecitabine 17Radiosurgery 16Celecoxib 16atezolizumab 15Filgrastim 15Amifostine 15130-nm albumin-bound paclitaxel 15fludarabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Head and Neck Neoplasms × Papillomavirus Vaccines × Clear all
NCT02865135 2024-01-11

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Dana-Farber Cancer Institute

Phase 1/2 Completed
11 enrolled 18 charts
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡